Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity
- PMID: 9507105
- DOI: 10.1016/s0005-2760(97)00172-0
Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity
Abstract
Characterization of the factors that regulate plasma cholesterol esterification shows that the increased activity of lecithin:cholesterol acyltransferase (LCAT) in the plasma of hyperlipidemic subjects is due to enhanced interactions with a preferred substrate. The details of how the physical properties of high density lipoproteins (HDL) may affect their ability to stimulate cholesterol esterification by LCAT have been investigated in homogeneous reconstituted HDL particles containing two molecules of apolipoprotein (apo) A-I (Lp2A-I) and palmitoyl-oleoyl phosphatidylcholine (POPC). Increasing the POPC or sphingomyelin (SPH) content in an Lp2A-I complex increases particle size and stability but decreases the negative surface charge of apoA-I. Increasing Lp2A-I POPC or SPH content also significantly inhibits cholesterol esterification by LCAT. Increase in the maximum rate of CE production (Vmax) by LCAT is directly related to an increased negative charge on the different Lp2A-I particles and to a reduced amount and stability of amphipathic alpha-helices in apoA-I. In contrast, increasing the Lp2A-I complex negative charge directly by addition of a charged lipid, phosphatidylinositol (PI), has minimal effect on apoA-I conformation and LCAT activation. While variations in Lp2A-I PI content have little effect on the interfacial binding of LCAT, increasing POPC content appears to directly increase the binding affinity of LCAT for the different Lp2A-I particles. These results show that LCAT is stimulated by an apoA-I conformation-dependent increase in negative charge but is less sensitive to electrostatic changes in the lipid interface of discoidal Lp2A-I. The activation of LCAT appears to be dependent on the exposure of both central (residues 98-132) and N-terminal (residues 2-8) domains in apoA-I. A strong relationship between the immunoreactivity of two specific mAbs, 4H1 and A11, and LCAT reactivity suggests that the N-terminus of apoA-I may interact with a central domain in a manner that may regulate the accessibility of LCAT to the edge of the disc. This indicates that the conformation and charge of apoA-I are sensitive to the surface-lipid composition of HDL particles and play a central role in regulating LCAT activation. Since alterations in the surface lipid composition of HDL particles from hyperlipidemic subjects also modify the charge and structure of these particles, this may stimulate the rates of cholesterol esterification by making these lipoproteins preferred LCAT substrates.
Copyright 1998 Elsevier Science B.V.
Similar articles
-
Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.Biochemistry. 1999 Feb 9;38(6):1727-35. doi: 10.1021/bi981945k. Biochemistry. 1999. PMID: 10026251
-
Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity.J Biol Chem. 1995 Mar 10;270(10):5151-7. doi: 10.1074/jbc.270.10.5151. J Biol Chem. 1995. PMID: 7890624
-
Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase. Importance of the central domain.J Biol Chem. 1993 Aug 15;268(23):16966-73. J Biol Chem. 1993. PMID: 7688720
-
Apolipoprotein A-I: structure-function relationships.J Lipid Res. 2000 Jun;41(6):853-72. J Lipid Res. 2000. PMID: 10828078 Review.
-
Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.Clin Chim Acta. 1999 Aug;286(1-2):257-71. doi: 10.1016/s0009-8981(99)00106-0. Clin Chim Acta. 1999. PMID: 10511297 Review.
Cited by
-
Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.J Pharmacol Exp Ther. 2020 Feb;372(2):193-204. doi: 10.1124/jpet.119.257568. Epub 2019 Nov 27. J Pharmacol Exp Ther. 2020. PMID: 31776208 Free PMC article.
-
Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.J Lipid Res. 2018 Feb;59(2):348-356. doi: 10.1194/jlr.M080986. Epub 2017 Dec 5. J Lipid Res. 2018. PMID: 29208698 Free PMC article.
-
Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity.Mol Cell Biochem. 2013 Jun;378(1-2):283-90. doi: 10.1007/s11010-013-1619-5. Epub 2013 Mar 21. Mol Cell Biochem. 2013. PMID: 23516040
-
Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity.Biochim Biophys Acta. 2012 Jun;1821(6):908-13. doi: 10.1016/j.bbalip.2012.02.007. Epub 2012 Feb 18. Biochim Biophys Acta. 2012. PMID: 22370449 Free PMC article.
-
Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate.Biochemistry. 2006 Apr 18;45(15):5029-38. doi: 10.1021/bi0600704. Biochemistry. 2006. PMID: 16605271 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous